Insufficient information to provide a comprehensive gene function summary. The provided PubMed abstracts address clinical conditions including shock, respiratory failure, COPD, obstetric emergencies, sepsis, pneumothorax, pulmonary embolism, and hemoptysis—none of which contain data about CCNQ (cyclin Q) function or related molecular mechanisms. Based on the provided metadata only: CCNQ is a cyclin that acts as an activating partner for CDK10, a cyclin-dependent kinase. According to UniProt annotations, CCNQ functions as a cyclin-dependent protein serine/threonine kinase regulator and participates in regulation of the G2/M phase transition during the cell cycle, with localization to the nucleus. CCNQ is located on the X chrX. The gene is associated with developmental abnormalities including toe syndactyly, telecanthus, and anogenital and renal malformations, suggesting critical roles in embryonic development. However, the molecular mechanisms by which CCNQ-CDK10 regulates cell cycle progression, specific substrate proteins, tissue-specific expression patterns, and detailed pathogenic mechanisms underlying associated developmental disorders cannot be established from the provided abstracts. Additional primary literature specifically investigating CCNQ biology would be required for a complete functional summary.